Primary |
Oral Herpes |
85.3% |
Product Used For Unknown Indication |
8.8% |
Drug Use For Unknown Indication |
4.0% |
Aphthous Stomatitis |
0.5% |
Chapped Lips |
0.3% |
Dermatitis |
0.1% |
Feeling Cold |
0.1% |
Pyrexia |
0.1% |
Acne |
0.1% |
Blister |
0.0% |
Bronchitis |
0.0% |
Dry Skin |
0.0% |
Fungal Infection |
0.0% |
Genital Herpes |
0.0% |
Herpes Simplex |
0.0% |
Herpes Zoster |
0.0% |
Liver Disorder |
0.0% |
Molluscum Contagiosum |
0.0% |
Prophylaxis |
0.0% |
Sensitivity Of Teeth |
0.0% |
|
Drug Ineffective |
55.5% |
Oral Herpes |
17.4% |
Herpes Simplex |
6.0% |
Product Quality Issue |
4.4% |
Drug Administration Error |
4.2% |
Swelling Face |
2.9% |
Intentional Drug Misuse |
2.4% |
Lip Swelling |
1.6% |
Application Site Irritation |
0.8% |
Scar |
0.7% |
Hypersensitivity |
0.6% |
Rash |
0.5% |
Pharmaceutical Product Complaint |
0.5% |
Application Site Pain |
0.5% |
Scab |
0.4% |
Application Site Swelling |
0.4% |
Lip Dry |
0.3% |
Lip Pain |
0.3% |
Lip Haemorrhage |
0.3% |
Pruritus |
0.3% |
|
Secondary |
Oral Herpes |
50.0% |
Herpes Virus Infection |
20.0% |
Product Used For Unknown Indication |
15.0% |
Crohn's Disease |
5.0% |
Herpes Simplex |
5.0% |
Rheumatoid Arthritis |
5.0% |
|
Oral Herpes |
20.0% |
Product Quality Issue |
20.0% |
Drug Ineffective |
13.3% |
Burning Sensation |
6.7% |
Drug Administration Error |
6.7% |
Lip Haemorrhage |
6.7% |
Mouth Ulceration |
6.7% |
Skin Exfoliation |
6.7% |
Stomatitis |
6.7% |
Wound Haemorrhage |
6.7% |
|
Concomitant |
Anxiety |
18.2% |
Rheumatoid Arthritis |
14.0% |
Drug Use For Unknown Indication |
9.1% |
Oral Herpes |
7.4% |
Product Used For Unknown Indication |
7.4% |
Constipation |
4.1% |
Diabetes Mellitus |
4.1% |
Hypothyroidism |
4.1% |
Pregnancy |
4.1% |
Prophylaxis |
4.1% |
Hormone Replacement Therapy |
3.3% |
Pain |
3.3% |
Asthma |
2.5% |
Psoriasis |
2.5% |
Rash |
2.5% |
Viral Upper Respiratory Tract Infection |
2.5% |
Abscess |
1.7% |
Arthritis |
1.7% |
Blood Pressure |
1.7% |
Chronic Lymphocytic Leukaemia |
1.7% |
|
Drug Ineffective |
13.3% |
Ventricular Septal Defect |
13.3% |
Chronic Obstructive Pulmonary Disease |
6.7% |
Oral Herpes |
6.7% |
Tendon Disorder |
6.7% |
Vision Blurred |
6.7% |
Bacterial Sepsis |
3.3% |
Bleeding Time Prolonged |
3.3% |
Constipation |
3.3% |
Death |
3.3% |
Deep Vein Thrombosis |
3.3% |
Dizziness |
3.3% |
Dysgeusia |
3.3% |
Endometrial Cancer Metastatic |
3.3% |
Headache |
3.3% |
Hypertension |
3.3% |
Injection Site Pain |
3.3% |
Injection Site Pruritus |
3.3% |
Pain |
3.3% |
Palpitations |
3.3% |
|